Terconazole
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-[4-[ [(2S,4S)-2-(2,4-Dichlorophenyl)-2- (1,2,4-triazol-1-ylmethyl)- 1,3-dioxolan-4-yl]methoxy]phenyl]- 4-propan-2-yl-piperazine | |
| Clinical data | |
| Trade names | Terazol |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a688022 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 94.9% |
| Identifiers | |
| CAS number | 67915-31-5 |
| ATC code | G01AG02 |
| PubChem | CID 441383 |
| DrugBank | APRD00659 |
| ChemSpider | 390122 |
| UNII | 0KJ2VE664U |
| KEGG | D00888 |
| ChEMBL | CHEMBL1306 |
| Chemical data | |
| Formula | C26H31Cl2N5O3 |
| Mol. mass | 532.462 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Terconazole is an anti-fungal medication, primarily used to treat vaginal fungal infections.
[edit] References
|
|||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
| This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |